Literature DB >> 6686324

Apparent involvement of opioid peptides in stress-induced enhancement of tumor growth.

J W Lewis, Y Shavit, G W Terman, L R Nelson, R P Gale, J C Liebeskind.   

Abstract

Exposure to stress has been associated with alterations in both immune function and tumor development in man and laboratory animals. In the present study, we investigated the effect of a particular type of inescapable footshock stress, known to cause an opioid mediated form of analgesia, on survival time of female Fischer 344 rats injected with a mammary ascites tumor. Rats subjected to inescapable footshock manifested an enhanced tumor growth indicated by a decreased survival time and decreased percent survival. This tumor enhancing effect of stress was prevented by the opiate antagonist, naltrexone, suggesting a role for endogenous opioid peptides in this process. In the absence of stress, naltrexone did not affect tumor growth.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6686324     DOI: 10.1016/0196-9781(83)90010-4

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  11 in total

1.  Immunoreactive opioid peptides in human breast cancer.

Authors:  L Scopsi; E Balslev; N Brünner; H S Poulsen; J Andersen; F Rank; L I Larsson
Journal:  Am J Pathol       Date:  1989-02       Impact factor: 4.307

2.  Differential effects of methionine enkephalin on the growth of brain tumor cells.

Authors:  Y S Lee; R D Wurster
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

3.  Evaluation of morphine effect on tumour angiogenesis in mouse breast tumour model, EATC.

Authors:  Funda Ustun; Gülay Durmus-Altun; Semsi Altaner; Nermin Tuncbilek; Cem Uzal; Sakir Berkarda
Journal:  Med Oncol       Date:  2010-06-22       Impact factor: 3.064

Review 4.  Naltrexone's Impact on Cancer Progression and Mortality: A Systematic Review of Studies in Humans, Animal Models, and Cell Cultures.

Authors:  Karina Liubchenko; Kevin Kordbacheh; Nika Khajehdehi; Tanja Visnjevac; Frederick Ma; James S Khan; Myles Storey; Alaa Abd-Elsayed; Ognjen Visnjevac
Journal:  Adv Ther       Date:  2020-12-18       Impact factor: 3.845

5.  Perioperative use of beta-blockers and COX-2 inhibitors may improve immune competence and reduce the risk of tumor metastasis.

Authors:  Marganit Benish; Inbal Bartal; Yael Goldfarb; Ben Levi; Roi Avraham; Amiram Raz; Shamgar Ben-Eliyahu
Journal:  Ann Surg Oncol       Date:  2008-04-09       Impact factor: 5.344

6.  Evidence for altered opioid activity in patients with cancer.

Authors:  P Lissoni; S Barni; F Paolorossi; S Crispino; F Rovelli; L Ferri; G Delitala; G Tancini
Journal:  Br J Cancer       Date:  1987-12       Impact factor: 7.640

7.  Morphine Promotes Tumor Angiogenesis and Increases Breast Cancer Progression.

Authors:  Sabrina Bimonte; Antonio Barbieri; Domenica Rea; Giuseppe Palma; Antonio Luciano; Arturo Cuomo; Claudio Arra; Francesco Izzo
Journal:  Biomed Res Int       Date:  2015-05-03       Impact factor: 3.411

Review 8.  Anesthetic techniques and cancer recurrence after surgery.

Authors:  Vincenzo Fodale; Maria G D'Arrigo; Stefania Triolo; Stefania Mondello; Domenico La Torre
Journal:  ScientificWorldJournal       Date:  2014-02-06

9.  Morphine, a potential antagonist of cisplatin cytotoxicity, inhibits cisplatin-induced apoptosis and suppression of tumor growth in nasopharyngeal carcinoma xenografts.

Authors:  Long-Hui Cao; Hui-Ting Li; Wen-Qian Lin; Hong-Ying Tan; Lan Xie; Zhong-Jian Zhong; Jian-Hua Zhou
Journal:  Sci Rep       Date:  2016-01-05       Impact factor: 4.379

Review 10.  The role of morphine in animal models of human cancer: does morphine promote or inhibit the tumor growth?

Authors:  Sabrina Bimonte; Antonio Barbieri; Giuseppe Palma; Claudio Arra
Journal:  Biomed Res Int       Date:  2013-08-28       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.